Long-Term Pharmacotherapy of Obesity 2000: A Review of Efficacy and Safety
This 2001 review analyzed long-term (≥36 weeks) placebo-controlled trials of obesity pharmacotherapy published since 1960. The study found that weight loss attributable to pharmacotherapy over 36–52 weeks was approximately 8.1% (7.9 kg) for phentermine resin, 5.0% (4.3 kg) for sibutramine, 3.4% (3.4 kg) for orlistat, and −1.5% (−1.5 kg) for
June 26, 2025
No Comments